Growth Metrics

C4 Therapeutics (CCCC) EBT Growth (3y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 C4 Therapeutics 561.03 Mn 325.36 Mn - 10.27%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.27%
Dec 31, 2025 18.18%
Sep 30, 2025 -0.22%
Jun 30, 2025 1.08%
Mar 31, 2025 5.93%
Dec 31, 2024 -30.05%
Sep 30, 2024 0.02%
Jun 30, 2024 7.77%
Mar 31, 2024 -10.59%
Dec 31, 2023 -16.30%
Sep 30, 2023 -5.77%
Jun 30, 2023 -48.54%
Mar 31, 2023 -42.27%
Dec 31, 2022 -54.32%
Sep 30, 2022 -50.13%